# Value Evidence, Pricing and Pipeline Access Therapeutic Area Lead, I2 at Roche

Roche is hiring a Value Evidence, Pricing and Pipeline Access Therapeutic Area Lead, I2 in Shanghai, China. Level rates it Little AI ●○○○; you can [apply on Roche](https://jobsbylevel.com/go/514785c5-d7c3-4f61-87ae-5741c7d2ac7a?utm_medium=ai-agent).

AI Level 1, AI centrality 38 out of 100. Shanghai.

## Details

- Company: [Roche](https://jobsbylevel.com/companies/roche)
- AI level: AI Level 1 (score 38 out of 100)
- Location: Shanghai
- Posted: November 5, 2026
- Apply: https://jobsbylevel.com/go/514785c5-d7c3-4f61-87ae-5741c7d2ac7a?utm_medium=ai-agent
- Free CV review for this job: https://jobsbylevel.com/cv-review?job=value-evidence-pricing-and-pipeline-access-therapeutic-area-lead-i2-at-roche-c01270

## Description

At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are, allowing you to thrive both personally and professionally. This is how we aim to prevent, stop and cure diseases and ensure everyone has access to healthcare today and for generations to come. Join Roche, where every voice matters. The Position Ÿ Principle Roles & Responsibilities / Accountabilities 主要职责/责任 (Major functions of the position) （职位的首要职能） 1. Pricing Strategy & Lifecycle Governance / 定价策略与生命周期治理 · Price-Volume & Analytics / 价格分析与洞察: Lead team to conduct price-volume and other relevant in-depth analysis, and lead external research if needed to advance understanding on access dynamics and pricing insights. · Lifecycle Pricing / 全生命周期价格策略: Develop pricing and financing proposals including PAP/PBP schemes for new product launch, national and local reimbursement listing, national volume-based purchasing (VBP), and other pricing-related events throughout the product’s lifecycle. · Business Plan Integration / 业务规划整合: Lead team to ensure that China product pricing is effectively integrated into business plans. · Pricing Governance & PC Management / 价格管理: Oversee company’s pricing governance for assigned TA and lead team to coordinate the planning of Roche China Pricing Committee (PC) meetings to review designated pricing topics. · Global Alignment & Endorsement / 总部沟通与对齐: Facilitate global pricing and management’s endorsement and concurrence on China proposals; ensure China pricing perspective is incorporated into respective global product pricing strategy via close correspondence with relevant global access pricing teams. · Pricing implementation / 定价策略执行: Work with cross-functional teams to ensure endorsed pricing strategies' implementation. 2. HE/HTA & Value Evidence Generation / 卫生经济学、HTA 与价值证据生成 · Design Value Proposition / 价值主张设计: Design key products value proposition based on collaboration and alignment with cross-functional colleagues including business units, strategic planning, medical affairs, and global access functions serving Roche China market priorities. · HEOR & Outcomes Studies / 卫生经济学与结果研究: Oversee the design and implementation of relevant health economics and outcomes studies, including disease burden study, CEA, BIA and epidemiological analyses if needed, or leverage RWD, to generate necessary evidence aligned with value proposition. · RWD & Payer-Driven Evidence Generation / 基于 RWD 与医保数据的证据产出: Drive RWD-based evidence generation, particularly leveraging healthcare and medical insurance claim database insights, to address key questions and priorities from payers and policy makers, while empowering compelling brand value narratives. · Milestone Alignment & Business Support / 节点对齐与商业准入支持: The evidence generation should meet the product launch, and pricing and reimbursement timeline to support product commercial and access objectives. 3. Pipeline Access & Early Value Readiness / 管线准入与早期价值准备 · Primary Contact & Early Input / 准入核心接口与早期输入: Serve as the primary contact for the access team at the pipeline stage across local cross-functional teams (e.g., Commercial, Medical, Regulatory) and between Global and China. Lead the team to develop pipeline pricing strategies, provide inputs into early trial designs and integrated evidence plans, formulate long-term pipeline value strategies, and collaborate on clinical trial investment decision recommendations. · Early Strategy Readiness / 早期策略准备: Ensure early access strategy readiness (encompassing pricing, value evidence, and policy) for strategic pipelines to maximize asset value post-launch. This involves developing product briefings, access profiling, and market positioning based on potential China market barriers and opportunities; conducting horizon scanning for policy changes and emerging payer trends; preparing reimbursement value

The description is cut here. Read the full offer: https://jobsbylevel.com/jobs/value-evidence-pricing-and-pipeline-access-therapeutic-area-lead-i2-at-roche-c01270

Source: https://jobsbylevel.com/jobs/value-evidence-pricing-and-pipeline-access-therapeutic-area-lead-i2-at-roche-c01270

## Cite this page

Level. https://jobsbylevel.com/jobs/value-evidence-pricing-and-pipeline-access-therapeutic-area-lead-i2-at-roche-c01270.

Get job alerts: https://jobsbylevel.com/newsletter